Characteristic | Apixaban (n = 314) |
Warfarin (n = 785) |
P value |
---|---|---|---|
Age (years), mean ± SD | 59.3 ± 13.9 | 57.7 ± 14.0 | .15 |
Men, n (%) | 164 (52.2) | 345 (43.9) | .01 |
Race, n (%) | |||
White | 220 (70.1) | 502 (63.9) | .39 |
Black | 77 (24.5) | 232 (29.6) | |
Hispanic | 7 (2.2) | 23 (2.9) | |
Asian | 0 (0) | 1 (0.1) | |
Other | 10 (3.2) | 27 (3.4) | |
Height (inches), mean ± SD | 68.1 ± 5.3 | 67.9 ± 5.0 | .66 |
Weight (kg), mean ± SD | 131.3 ± 22.9 | 139.5 ± 30.1 | <.01 |
BMI (kg/m2), mean ± SD | 44.1 ± 6.8 | 47.1 ± 10.4 | <.01 |
Past medical history, n (%) | |||
Alcohol use disorder | 20 (6.4) | 26 (3.3) | .03 |
Active smoker | 55 (17.5) | 171 (21.8) | .12 |
Active cancer | 27 (8.6) | 42 (5.4) | .05 |
Chronic kidney disease | 57 (18.2) | 147 (18.7) | .86 |
Diabetes mellitus | 74 (23.6) | 363 (46.2) | <.01 |
Coagulation disorder* | 22 (7.0) | 80 (10.2) | .11 |
AF | 49 (15.6) | 97 (12.4) | .17 |
History of stroke | 21 (6.7) | 32 (4.1) | .09 |